Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 22, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 22, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement Post author:GHIAA Admin Post published:September 10, 2021 Post category: Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
AUTM Model Inter-Institutional Research Collaboration Agreement Post author:GHIAA Admin Post published:August 19, 2021 Post category: Continue ReadingAUTM Model Inter-Institutional Research Collaboration Agreement
NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement Post author:GHIAA Admin Post published:December 14, 2020 Post category: Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement Post author:GHIAA Admin Post published:December 14, 2020 Post category: Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
BMS – MPP Sublicense & Tech Transfer Agreement Post author:Loren Post published:May 23, 2020 Post category: Continue ReadingBMS – MPP Sublicense & Tech Transfer Agreement